TMDX vs. DXCM

In the year-to-date period, TMDX achieves a 49.96% return, which is significantly higher than DXCM's -7.86% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for TransMedics Group, Inc. (TMDX) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current TMDX Sharpe Ratio is 0.05, which is higher than the DXCM Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of TMDX and DXCM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither TMDX nor DXCM has paid dividends to shareholders.

The maximum TMDX drawdown since its inception was -73.69%, smaller than the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for TMDX and DXCM. For additional features, visit the drawdowns tool.

TransMedics Group, Inc. (TMDX) and DexCom, Inc. (DXCM) have volatilities of 17.52% and 17.68%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between TransMedics Group, Inc. and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.